Artificial intelligence (AI) is being increasingly integrated into scientific discovery to augment
and accelerate research, hel** scientists to generate hypotheses, design experiments …

In many ways, graphs are the main modality of data we receive from nature. This is due to
the fact that most of the patterns we see, both in natural and artificial systems, are elegantly …

Networks—or graphs—are universal descriptors of systems of interacting elements. In
biomedicine and healthcare, they can represent, for example, molecular interactions …

Develo** personalized diagnostic strategies and targeted treatments requires a deep
understanding of disease biology and the ability to dissect the relationship between …

Drug repurposing—identifying new therapeutic uses for approved drugs—is often a
serendipitous and opportunistic endeavour to expand the use of drugs for new diseases …

Artificial intelligence (AI) is poised to transform therapeutic science. Therapeutics Data
Commons is an initiative to access and evaluate AI capability across therapeutic modalities …

A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

Drug repurposing or repositioning is a technique whereby existing drugs are used to treat
emerging and challenging diseases, including COVID-19. Drug repurposing has become a …

Graph machine learning (GML) is receiving growing interest within the pharmaceutical and
biotechnology industries for its ability to model biomolecular structures, the functional …

Understanding protein function and develo** molecular therapies require deciphering the
cell types in which proteins act as well as the interactions between proteins. However …